Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells

Journal of Lipid Research

Volumn 37, Issue 4, 1996, Pages 810-824

  Dashti, Nassrin ^a   Franklin, Frank A ^a   Abrahamson, Dale R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Acyl CoA:cholesterol acyltransferase; apoE; Cholesteryl esters; LDL receptor; Liver; mRNA; Pfizer CP 113,818; Triglycerides; Unesterified cholesterol

Indexed keywords

ALCOHOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LIPOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LIPID STORAGE; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER CELL CULTURE; PRIORITY JOURNAL;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CELL LINE; CELL SURVIVAL; CHOLESTEROL ESTERS; ETHANOL; HUMANS; LIPOPROTEINS; LIVER; MODELS, BIOLOGICAL; RECEPTORS, LDL; RNA, MESSENGER; TIME FACTORS; TRIGLYCERIDES;

EID: 0029971273     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Gofman, J. W., W. Young, and R. Tandy. 1966. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 34: 679-697.
2. Gordon, T., W. P. Kannel, and W. P. Castelli. 1981. Lipoproteins, cardiovascular disease, and death. Arch. Intern. Med. 141: 1128-1131.
3. Gordon, T., W. P. Castelli, M. C. Hjortland, W. P. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 62: 707-714.
4. Castelli, W. P., J. T. Doyle, T. Gordon, C. G. Hames, M. C. Hjortland, S. B. Hulley, A. Kagan, and W. J. Zukel. 1977. HDL cholesterol and other lipids in coronary heart disease. Circulation. 55: 767-772.
5. Brunzell, J. D., A. D. Sniderman, and J. J. Albers. 1984. Apoproteins B and A-I and coronary artery disease in human. Atherosclerosis. 4: 79-83.
6. Gruchow, H. W., R. G. Hoffmann, A. J. Anderson, and J. J. Barboriak. 1982. Effects of drinking patterns on the relationship between alcohol and coronary occlusion. Atherosclerosis. 43: 393-404.
7. Gordon, T., and W. D. Kannel. 1983. Drinking habits and cardiovascular disease: the Framingham Study. Am. Heart J. 105: 667-673.
8. Klatsky, A. L., M. A. Armstrong, and G. D. Friedman. 1990. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am. J. Cardiol. 66: 1237-1242.
9. Stampfer, M. J., G. A. Colditz, W. C. Willett, F. E. Speizer, and C. H. Hennekens. 1988. A prospective study of coronary disease and stroke in women. N. Engl. J. Med. 319: 267-273.
10. Colditz, G. A., L. G. Branch, R. J. Lipnick, W. C. Willett, B. Rosner, B. Posner, and C. H. Hennekens. 1985. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am. Heart J. 109: 886-889.
11. Gaziano, J. M., J. E. Buring, J. L. Breslow, S. Z. Goldhaber, B. Rosner, M. VanDenburgh, W. Willett, and C. H. Hennekens. 1993. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med. 329: 1829-1834.
12. Deutscher, S., H. E. Rockette, and V. Krishnaswami. 1984. Evaluation of habitual excessive alcohol consumption on myocardial infarction risk in coronary disease patients. Am. Heart J. 108: 988-995.
13. Castelli, W. P., J. T. Doyle, T. Gordan, C. G. Hames, M. C. Hjortland, S. B. Hulley, A. Kagan, and W. J. Zukel. 1977. Alcohol and blood lipids. Lancet. 2: 153-155.
14. Hulley, S. B., and S. Gordon. 1981. Alcohol and high density lipoprotein cholesterol. Circulation. 64:57-62 (Suppl. 3).
15. Ernst, N., M. Fisher, and W. Smith. 1980. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. Circulation. 62: 41-51 (Suppl. 4).
16. Grouse, J. R., and S. M. Grundy. 1984. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J. Lipid Res. 25: 486-496.
17. Taskinen, M. R., M. Valimaki, E. A. Nikkila, T. Kuusi, C. Ehnholm, and R. Ylikahri. 1982. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism. 31: 1168-1174.
18. Ostrander, L. D., D. E. Lamphear, W. D. Block, B. C. Johnson, C. Bevencroft, and F. H. Epstein. 1974. Relationship of serum lipid concentrations to alcohol consumption. Arch. Intern. Med. 134: 451-456.
19. Goldberg, C. S., A. R. Tall, and S. Krumholz. 1984. Acute inhibition of lipase and increase in plasma lipoproteins after alcohol intake. J. Lipid Res. 25: 714-720.
20. Taskinen, M. R., E. A. Nikkila, M. Valimaki, T. Sane, T. Kuusi, K. Antero, and R. Ylikahri. 1987. Alcohol-induced changes in serum lipoproteins and in their metabolism. Am. Heart J. 113:458-464.
21. Baraona, E., and C. S. Lieber. 1979. Effects of ethanol on lipid metabolism. J. Lipid Res. 20: 289-315.
22. Valimaki, M., M. R. Taskinen, R. Ylikahri, R. Roine, T. Kuusi, and E. A. Nikkila. 1988. Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study. Eur. J. Clin. Invest. 18: 472-480.
23. Masarei, J. R. L., I. B. Puddey, I. L. Rouse, W. J. Lynch, R. Vandongen, and L. J. Beilin. 1986. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Atherosclerosis. 60: 79-87.
24. Camargo, C. A., Jr., P. T. Williams, K. M. Vranizan, J. J. Albers, and P. D. Wood. 1985. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. J. Am. Med. Assoc. 253: 2854-2857.
25. Hartung, G. H., J. P. Foreyt, R. S. Reeves, L. P. Krock, W. Patsch, J. R. Patsch, and A. M. Gotto, Jr. 1990. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. Metabolism. 39: 81-86.
26. Dashti, N. 1992. Acute effects of alcohol on hepatic lipoprotein production. 65th Scientific Sessions of the American Heart Association. 132.
27. Dashti, N., and G. Wolfbauer. 1987. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J. Lipid Res. 28: 423-436.
28. Dashti, N., D. L. Williams, and P. Alaupovic. 1989. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J. Lipid Res. 30: 1365-1373.
29. Dashti, N. 1992. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J. Biol. Chem. 267: 7160-7169.
30. Lee, D. M., and P. Alaupovic. 1986. Apolipoproteins B, C-III and E in two major subpopulations of low-density lipoproteins. Biochim. Biophys. Acta. 879: 126-133.
31. Bonnichsen, R. 1965. Ethanol determination with alcohol dehydrogenase and DPN. In Methods of Enzymatic Analysis. H. U. Bergmeyer, editor. Verlag Chemie Academic Press, New York, NY. 285-287.
32. Bergmeyer, H. U., E. Bernt, and B. Hess. 1965. Lactic dehydrogenase. In Methods of Enzymatic Analysis. H. U. Bergmeyer, editor. Verlag Chemie Academic Press, New York, NY. 736-743.
33. Kuksis, A., J. J. Myher, L. Marai, and K. Geher. 1975. Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis. J. Chromatogr. Sci. 13: 423-430.
34. Curry, M. D., P. Alaupovic, and C. A. Suenram. 1976. Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin. Chem. 22: 315-322.
35. Curry, M. D., A. Gustafson, P. Alaupovic, and W. J. McConathy. 1978. Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin. Chem. 24: 280-286.
36. Curry, M. D., W. J. McConathy, P. Alaupovic, J. H. Ledford, and M. Popovic. 1976. Determination of human apolipoprotein E by electroimmunoassay. Biochim. Biophys. Acta. 439: 413-425.
37. Dashti, N., P. Alaupovic, C. Knight-Gibson, and E. Koren. 1987. Identification and partial characterization of discrete apolipoprotein B-containing lipoprotein particles produced by human hepatoma cell line HepG2. Biochemistry. 26: 4837-4846.
38. Dashti, N., E. Koren, and P. Alaupovic. 1989. Identification and partial characterization of discrete apolipoprotein A-containing lipoprotein particles secreted by human hepatoma cell line HepG2. Biochem. Biophys. Res. Commun. 163: 574-580.
39. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
40. Dixon, J. L., S. Furukawa, and H. N. Ginsberg. 1991. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266: 5080-5086.
41. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
42. Chirgwin, J. M., A. E. Przylbyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources. Biochemistry. 18: 5294-5299.
43. Williams, D. L., T. C. Newman, G. S. Shelness, and D. A. Gordon. 1985. Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. Methods Enzymol. 128: 671-689.
44. Sorci-Thomas, M., M. M. Prack, N. Dashti, F. Johnson, L. L. Rudel, and D. L. Williams. 1988. Apolipoprotein (apo) A-I productions and mRNA abundance explain plasma apoA-I and high density lipoprotein difference between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J. Biol. Chem. 263: 5183-5189.
45. Dashti, N., G. Wolfbauer, E. Koren, B. B. Knowles, and P. Alaupovic. 1984. Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. Biochim. Biophys. Acta. 794: 373-384.
46. Marzetta, C. A., Y. E. Savoy, A. M. Freeman, C. A. Long, J. L. Pettini, R. E. Hagar, P. B. Inskeep, K. Davis, A. F. Stucchi, R. J. Nicolosi, and E. S. Hamanaka. 1994. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys. J. Lipid Res. 35: 1829-1838.
47. Markwell, M. A. K. 1982. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal. Biochem. 125:427-432.
48. Wolfla, C. E., R. A. Ross, and D. W. Crabb. 1988. Induction of alcohol dehydrogenase activity and mRNA in hepatoma cells by dexamethasone. Arch. Biochem. Biophys. 263: 69-76.
49. Lieber, C. S. 1987. Microsomal ethanol oxidizing system. Enzyme. 37: 45-56.
50. Tam, S. P. 1992. Effect of ethanol on lipoprotein secretion in two human hepatoma cell lines, HepG2 and Hep3B. Alcohol. Clin. Exp. Res. 16: 1021-1028.
51. Lieber, C. S. 1988. The microsomal ethanol oxidizing system: its role in ethanol and xenobiotic metabolism. Biochem. Soc. Trans. 16: 232-239.
52. Grunnet, N., J. Kondrup, and J. Dich. 1985. Effect of ethanol on lipid metabolism in cultured hepatocytes. Biochem. J. 228: 673-681.
53. Polokoff, M. A., M. Iwahashi, and F. R. Simon. 1983. Ethanol treatment increases triacylglycerol and cholesteryl ester content of cultured hepatoma cells. J. Lipid Res. 24: 1030-1038.
54. Ontko, J. A. 1973. Effects of ethanol on the metabolism of free fatty acids in isolated liver cells. J. Lipid Res. 14: 78-86.
55. Cianflone, K. M., Z. Yasruel, M. A. Rodrguez, D. Vas, and A. D. Sniderman. 1990. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31: 2045-2055.
56. Wu, X., N. Sakata, E. Lui, and H. N. Ginsberg. 1994. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J. Biol. Chem. 269: 12375-12382.
57. Dixon, J. L., and H. N. Ginsberg. 1993. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34: 167-179.
58. Adeli, K., and A. Theriault. 1992. Insulin modulation of human apolipoprotein B mRNA translation: studies in an in vitro cell-free system from HepG2 cells. Biochem. Cell Biol. 70: 1301-1312.
59. Goldberg, D. M., J. G. Parkes, and S. Hahn. 1989. Microsomal induction, alcohol, and lipoprotein metabolism: is there a three-way relationship? Clin. Biochem. 22: 57-67.
60. Amarasuriya, R. N., A. K. Gupta, M. Civen, Y. C. Horng, T. Maeda, and M. L. Kashyap. 1992. Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: implications for a mechanism for atherosclerosis protection. Metabolism. 41: 827-832.
61. Wang, T. W. M., C. D. Byrne, and C. N. Hales. 1994. Effect of ethanol on hepatic apolipoprotein B synthesis and secretion in vitro. Biochim. Biophys. Acta. 1211: 234-238.
62. Valimaki, M., K. Laitinen, R. Ylikahrit, C. Ehnholm, M. Jauhianinen, J. M. Bard, J. C. Fruchart, and M. R. Taskinen. 1991. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein(a). Metabolism. 40: 1168-1172.
63. Hojnacki, J. L., J. E. Cluette-Brown, R. N. Deschenes, J. J. Mulligan, T. V. Osmolski, N. J. Rencricca, and J. J. Barboriak. 1992. Alcohol produces dose-dependent antiatherogenic and atherogenic plasma lipoprotein responses. Proc. Soc. Exp. Biol. Med. 200: 67-77.
64. Hoensch, H. 1987. Ethanol as enzyme inducer and inhibitor. Pharmacol. Ther. 33: 121-128.
65. Luoma, P. V., E. A. Sotaniemi, R. O. Pelkonen, and C. Ehnholm. 1982. High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers. Res. Commun. Chem. Pathol. Pharmacol. 37: 91-96.
66. Thrift, R. N., T. M. Forte, B. E. Cahoon, and V. G. Shore. 1986. Characterization of lipoproteins produced by the human liver cell line, HepG2, under defined conditions. J. Lipid Res. 27: 236-250.
67. Klatsky, A. L. 1994. Epidemiology of coronary heart disease: influence of alcohol. Alcohol. Clin. Exp. Res. 18: 88-96.
68. Suh, I., B. J. Shaten, J. A. Cutler, and L. H. Kuller. 1992. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann. Intern. Med. 116: 881-887.